Filter Results:
(518)
Show Results For
- All HBS Web
(831)
- People (1)
- News (135)
- Research (518)
- Events (3)
- Multimedia (7)
- Faculty Publications (414)
Show Results For
- All HBS Web
(831)
- People (1)
- News (135)
- Research (518)
- Events (3)
- Multimedia (7)
- Faculty Publications (414)
Sort by
- August 1998
- Case
Electronic Commerce at Air Products
By: F. Warren McFarlan and Melissa Dailey
In 1998,chief information officers (CIOs) in the highly competitive international gases and chemicals business faced the reality that electronic commerce capability was a strategic necessity. The results of annual surveys of technology officers in the chemical industry... View Details
Keywords: Management Teams; Information Technology; Globalized Markets and Industries; Infrastructure; Internet and the Web; Technology Adoption; Business Strategy; Chemical Industry; United States
McFarlan, F. Warren, and Melissa Dailey. "Electronic Commerce at Air Products." Harvard Business School Case 399-035, August 1998.
- March 2000
- Article
The Duality of Collaboration: Inducements and Opportunities in the Formation of Interfirm Linkages
By: Gautam Ahuja
I argue that the linkage-formation propensity of firms is explained by simultaneously examining both inducement and opportunity factors. Drawing upon resource-based and social network theory literatures I identify three forms of accumulated... View Details
Keywords: Collaboration; Innovation; Networks; Strategy; Alliances; Social and Collaborative Networks; Innovation and Invention; Chemical Industry
Ahuja, Gautam. "The Duality of Collaboration: Inducements and Opportunities in the Formation of Interfirm Linkages." Special Issue on Strategic Networks edited by Ranjay Gulati, Nitin Nohria, Akbar Zaheer. Strategic Management Journal 21, no. 3 (March 2000): 317–343.
- February 1985 (Revised July 1986)
- Case
Applichem (A)
Applichem has six plants in different countries making the same chemical product. The purpose of this case is to allow students to think about what costs are relevant to management in this process industry environment, about how to define a comparison of costs and... View Details
Keywords: Business or Company Management; Multinational Firms and Management; Performance Productivity; Operations; Performance Improvement; Chemical Industry
Flaherty, Marie-Therese M. "Applichem (A)." Harvard Business School Case 685-051, February 1985. (Revised July 1986.)
- Article
Entrepreneurship in the Large Corporation: A Longitudinal Study of How Established Firms Create Breakthrough Inventions
By: Gautam Ahuja and Curba Morris Lampert
We present a model that explains how established firms create breakthrough inventions. We identify three organizational pathologies that inhibit breakthrough inventions: the familiarity trap—favoring the familiar; the maturity trap—favoring the mature;... View Details
Keywords: Radical Innovation; Organizational Learning; Technology; Strategy; Corporate Entrepreneurship; Business Processes; Innovation and Invention; Chemical Industry
Ahuja, Gautam, and Curba Morris Lampert. "Entrepreneurship in the Large Corporation: A Longitudinal Study of How Established Firms Create Breakthrough Inventions." Special Issue on Strategic Entrepreneurship: Entrepreneurial Strategies for Wealth Creation. Strategic Management Journal 22, nos. 6-7 (June–July 2001): 521–543.
- July 2008 (Revised June 2012)
- Case
Corruption in Germany
By: Rawi E. Abdelal, Rafael Di Tella and Jonathan Schlefer
Why do managers become corrupt? Does corruption ever pay? When do friendly relations cross into bribery? How can CEOs manage and prevent outbreaks of corruption? These and other questions are raised by three short case studies of corruption in Germany: at the global... View Details
Abdelal, Rawi E., Rafael Di Tella, and Jonathan Schlefer. "Corruption in Germany." Harvard Business School Case 709-006, July 2008. (Revised June 2012.)
- February 2011 (Revised October 2018)
- Case
ALAC International
By: Richard S. Ruback and Royce Yudkoff
ALAC was a small importer of specialty industrial chemicals. The case explores the different financing alternatives to facilitate the company's explosive growth in working capital. At the end of 2009, the company was awarded the United States distributorship for the... View Details
Ruback, Richard S., and Royce Yudkoff. "ALAC International." Harvard Business School Case 211-065, February 2011. (Revised October 2018.)
- April 2017 (Revised August 2018)
- Case
The U.S. Shale Revolution: Global Rebalancing?
By: Laura Alfaro and Richard H.K. Vietor
The American shale revolution has upended oil and gas markets for nearly a decade. Prices have risen then plunged, production has surged and then waned, LNG has boomed, and technology and productivity have improved. The U.S. energy policy, under the Obama... View Details
Keywords: Shale Oil; Shale Gas; LNG; Energy Policy; Drilling Technology; Energy; Trade; Economics; Macroeconomics; Policy; Energy Industry; Manufacturing Industry; United States; Middle East
Alfaro, Laura, and Richard H.K. Vietor. "The U.S. Shale Revolution: Global Rebalancing?" Harvard Business School Case 717-056, April 2017. (Revised August 2018.)
- August 1993
- Case
Applichem (A) (Abridged)
By: Janice H. Hammond and Gary P. Pisano
Applichem manufactures the same chemical product in four plants, each of which is located in a different country. The company has completed a major study comparing the productivity and performance of these plants. Using the data from the study, students must decide... View Details
Keywords: Business or Company Management; Management Practices and Processes; Performance Productivity; Performance Efficiency; Performance Evaluation; Strategy; Judgments; Factories, Labs, and Plants; Business Exit or Shutdown; Chemical Industry
Hammond, Janice H., and Gary P. Pisano. "Applichem (A) (Abridged)." Harvard Business School Case 694-030, August 1993.
- February 2010
- Case
Amyris Biotechnologies: Commercializing Biofuel
By: Gary P. Pisano and Alison Berkley Wagonfeld
In 2009, Amyris Biotechnologies was building a plant in Brazil that used synthetic biology to convert sugarcane into both renewable fuels and renewable chemicals. The Amyris' marketing team was investigating the commercial interest for both types of products, while the... View Details
Keywords: Renewable Energy; Chemicals; Risk Management; Product Marketing; Product Development; Production; Environmental Sustainability; Commercialization; Biotechnology Industry; Brazil
Pisano, Gary P., and Alison Berkley Wagonfeld. "Amyris Biotechnologies: Commercializing Biofuel." Harvard Business School Case 610-031, February 2010.
- July 2015 (Revised March 2021)
- Case
Proxy Contest at DuPont
By: Jay W. Lorsch and Emily McTague
On January 9, 2015, Nelson Peltz of Trian Fund Management launched a proxy fight for four out of the twelve seats on the DuPont board. The fund had previously published a public letter addressed to shareholders outlining its proposal to break the company into three... View Details
Keywords: Board Of Directors; Hedge Fund; Activist Investing; Activist Investors; Proxy Fight; Corporate Governance; Governing and Advisory Boards; Investment Activism; Chemical Industry; United States
Lorsch, Jay W., and Emily McTague. "Proxy Contest at DuPont." Harvard Business School Case 416-005, July 2015. (Revised March 2021.)
- September 1991 (Revised February 1993)
- Case
Burroughs Wellcome and AZT (A)
Burroughs Wellcome Co., developer of AZT, the first drug approved by the U.S. Food and Drug Administration for the treatment of Acquired Immune Deficiency Syndrome (AIDS), finds itself under siege in September 1989 by AIDS activists and various segments of the U.S.... View Details
Keywords: Governing Rules, Regulations, and Reforms; Ethics; Business and Government Relations; Communication Strategy; Health Care and Treatment; Monopoly; Intellectual Property; Research and Development; Price; Pharmaceutical Industry; London
Emmons, Willis M., III. "Burroughs Wellcome and AZT (A)." Harvard Business School Case 792-004, September 1991. (Revised February 1993.)
- September 1996 (Revised December 1997)
- Case
Cytec Industries' Spin-Off (A): Sink or Swim?
In the wake of market pressure to restructure, American Cyanamid spun off its poorly performing Chemicals Unit into a new publicly traded corporation, Cytec Industries. In addition to weak operations, Cytec inherited the bulk of Cyanamid's environmental and... View Details
Keywords: Organizational Change and Adaptation; Management Practices and Processes; Restructuring; Performance Improvement; Chemical Industry; United States
Wruck, Karen, and Sherry P. Roper. "Cytec Industries' Spin-Off (A): Sink or Swim?" Harvard Business School Case 897-053, September 1996. (Revised December 1997.)
- October 1994 (Revised January 1995)
- Case
Rhone-Poulenc (A) and (B) Condensed
Rhone-Poulenc, France's largest chemical firm, has achieved a major position in the United States as the result of an ambitious series of acquisitions. As it expanded in the United States from 1986 to 1990, Rhone-Poulenc management sought to take a "hands-off" approach... View Details
Keywords: Organizational Change and Adaptation; Multinational Firms and Management; Organizational Structure; Chemical Industry; France; United States
Rosenzweig, Philip M. "Rhone-Poulenc (A) and (B) Condensed." Harvard Business School Case 395-042, October 1994. (Revised January 1995.)
- September 1993
- Case
Rhone-Poulenc (B)
Rhone-Poulenc, France's largest chemical firm, has achieved a major position in the United States as the result of an ambitious series of acquisitions. As it expanded in the United States from 1986 to 1990, Rhone-Poulenc management sought to take a "hands-off" approach... View Details
Keywords: Organizational Change and Adaptation; Multinational Firms and Management; Organizational Structure; Chemical Industry; France; United States
Rosenzweig, Philip M. "Rhone-Poulenc (B)." Harvard Business School Case 394-041, September 1993.
- 2022
- Article
Missing Novelty in Drug Development
By: Joshua Krieger, Danielle Li and Dimitris Papanikolaou
We provide evidence that risk aversion leads pharmaceutical firms to underinvest in radical innovation. We introduce a new measure of drug novelty based on chemical similarity and show that firms face a risk-reward trade-off: novel drug candidates are less likely to... View Details
Keywords: Drug Development; Risk Aversion; Research and Development; Innovation and Invention; Investment; Pharmaceutical Industry
Krieger, Joshua, Danielle Li, and Dimitris Papanikolaou. "Missing Novelty in Drug Development." Review of Financial Studies 35, no. 2 (February 2022): 636–679.
- 2009
- Working Paper
Firsthand Experience and the Subsequent Role of Reflected Knowledge in Cultivating Trust in Global Collaboration
By: Mark Mortensen and T. B. Neeley
While scholars contend that firsthand experience—time spent onsite observing the people, places, and norms of a distant locale—is crucial in globally distributed collaboration, how such experience actually affects interpersonal dynamics is poorly understood. Based on... View Details
Keywords: Interpersonal Communication; Experience and Expertise; Globalized Firms and Management; Knowledge Acquisition; Knowledge Use and Leverage; Trust
Mortensen, Mark, and T. B. Neeley. "Firsthand Experience and the Subsequent Role of Reflected Knowledge in Cultivating Trust in Global Collaboration." Harvard Business School Working Paper, No. 09-131, May 2009. (Under second review, Management Science.)
- July 2021
- Teaching Note
The Carlyle Group: Carving Out Atotech
Teaching Note for HBS Case No. 321-153. On January 31, 2017, The Carlyle Group ("Carlyle") closed its $3.2 billion acquisition of Atotech, an international Specialty Chemicals and Equipment company. In Carlyle's Washington, DC headquarters, the US-based deal... View Details
- July 1997 (Revised April 1998)
- Case
Chase Manhattan Corporation: The Making of America's Largest Bank
By: Stuart C. Gilson and Cedric Escalle
Chase Bank and Chemical Bank intend to merge, producing the largest commercial bank in the United States, the fourth largest in the world. Projected financial benefits under the merger reflect significant planned reduction in operating costs, including 17,000 employee... View Details
Keywords: Commercial Banking; Profit; Corporate Strategy; Value Creation; Restructuring; Negotiation; Mergers and Acquisitions; Risk and Uncertainty; Resignation and Termination; Revenue; Banking Industry; United States
Gilson, Stuart C., and Cedric Escalle. "Chase Manhattan Corporation: The Making of America's Largest Bank." Harvard Business School Case 298-016, July 1997. (Revised April 1998.)
- October 1990 (Revised April 1991)
- Case
RU 486 (A)
Describes the factors faced by Roussel UCLAF, a French drug company, in deciding whether and how to market a controversial new drug, RU 486, which is often called "the French abortion pill." Roussel's decision involved its relations with the French government, its... View Details
Keywords: Judgments; Ethics; Product Launch; Negotiation; Outcome or Result; Performance; Business and Government Relations; Health Industry; Pharmaceutical Industry; France; Germany; United States
Badaracco, Joseph L., Jr. "RU 486 (A)." Harvard Business School Case 391-050, October 1990. (Revised April 1991.)
- October 1992 (Revised August 1994)
- Case
Allied-Signal: Managing the Hazardous Waste Liability Risk
By: Richard H.K. Vietor and Edward Prewitt
Allied-Signal, Inc., one of the world's oldest chemical companies and today a diversified conglomerate, is liable for clean-up costs of old hazardous waste sites. These costs are substantial: reserves grew to nearly $500 million in 1991. Attempting to avoid further... View Details
Keywords: Wastes and Waste Processing; Environmental Sustainability; Programs; Cost Management; Policy; Government Legislation; Factories, Labs, and Plants; Governance Compliance; Legal Liability; Chemical Industry; United States; Europe
Vietor, Richard H.K., and Edward Prewitt. "Allied-Signal: Managing the Hazardous Waste Liability Risk." Harvard Business School Case 793-044, October 1992. (Revised August 1994.)